Inhibition by dietary benzylselenocyanate of hepatocarcinogenesis induced by azoxymethane in Fischer 344 rats.
The effect of dietary benzylselenocyanate (BSC), a novel organoselenium compound and its sulfur analog, benzylthiocyanate (BTC), on hepatocarcinogenesis induced by azoxymethane (AOM) was investigated in male F344 rats. Eighty-one weanling rats were divided into 3 groups and were raised on a semipurified diet (control diet). Starting from 5 weeks of age, groups of animals consuming the control diet were fed one of the experimental diets containing 25 ppm BSC or BTC. An additional group was continued on the control diet. At 7 weeks of age, animals were given weekly sc injections of AOM (15 mg/kg body weight once weekly for 2 weeks). One week after the second AOM injection, those groups receiving BSC and BTC diets were transferred to the control diet and continued on this diet until termination of the experiment at 34 weeks after the last AOM injection. For quantitative analysis of enzyme-altered liver cell foci, glutathione S-transferase placental form was stained by an immunohistochemical technique. The results indicate that the incidence and the density of the enzyme-altered foci were significantly lower in AOM-treated rats fed the diet containing 25 ppm BSC (foci incidence 56%, foci density 2.43/cm2) than in AOM-treated animals fed the control diet (foci incidence 92%, foci density 4.79/cm2). The incidence of small altered foci was significantly inhibited in rats fed the BTC diet (35%) as compared to those fed the control diet (68%), but the degree of inhibition was more pronounced in animals fed the BSC diet than in those fed the BTC diet.
Sugie
S
S
Division of Experimental Pathology, Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, NY 10595.
Reddy
B S
BS
el-Bayoumy
K
K
Tanaka
T
T
D000818:Animals; D001391:Azo Compounds; D001397:Azoxymethane; D003485:Cyanates / Q000008:administration & dosage / Q000627:therapeutic use*; D004032:Diet; D005982:Glutathione Transferase / Q000032:analysis; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D016566:Organoselenium Compounds; D051381:Rats; D011916:Rats, Inbred F344
D001391:Azo Compounds; D003485:Cyanates; D016566:Organoselenium Compounds; C054108:benzyl selenocyanate; D005982:Glutathione Transferase; D001397:Azoxymethane